Gene Therapy Program | University of Pennsylvania

Dedicated to discovery + translational research and led by Dr James Wilson, the Gene Therapy Program at the University of Pennsylvania focuses on the development of next-generation gene transfer vectors and their application in the treatment of a variety of acquired and inherited diseases.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

AGC BIOLOGICS TO PARTICIPATE IN FIRST-EVER BIO DIGITAL CONFERENCE

AGC Biologics | May 14, 2020

news image

AGC Biologics, a global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), will be participating in the first-ever BIO Digital event. BIO International Conference is holding its annual event virtually this year in order to safely connect industry experts amidst the COVID-19 global pandemic. The event, which takes place June 8 - 12, brings together capital, scientific and development expertise that is required to turn promising innovation into successful medicine....

Read More

CELL AND GENE THERAPY

BIOINVENT AND TRANSGENE RECEIVE CTA APPROVAL FOR PHASE L/LLA STUDY OF NOVEL ONCOLYTIC VACCINIA VIRUS BT-001

BioInvent | December 22, 2020

news image

BioInvent International AB ("BioInvent") (OMXS: BINV), a biotech organization focused in on the discovery and development of novel and first-in-class immune-modulatory antibodies for cancer immunotherapy, and Transgene (Euronext Paris: TNG), a biotech organization that designs and develops infection based for the therapy of cancer, reported they have received administrative endorsement in Belgium for a clinical trial application (CTA) for a Phase l/lla study of the novel oncolytic vacc...

Read More

MEDTECH

BIOTECH START-UP AANIKA BIOSCIENCES LANDS INITIAL $12M FUNDING FOR CUTTING-EDGE FOOD TRACING TECHNOLOGY

Aanika Biosciences | December 01, 2021

news image

Biotech start-up Aanika Biosciences today announced the initial closing of its $12 million Series A round, led by Jon Cholak of Adit Ventures along with existing investors Draper Associates and SOSV. The investment will help scale the company’s food tracing technology platform, advance research and expand its Brooklyn food safety and manufacturing facility to approximately 30,000 square feet. Aanika's proprietary technology is designed to accelerate the speed and accurac...

Read More

INDUSTRIAL IMPACT

CELLARITY EXPANDS LEADERSHIP TEAM TO CONTINUE EVOLUTION OF A BREAKTHROUGH PLATFORM TO ENCODE BIOLOGY AND PURPOSEFULLY CREATE NEW MEDICINES

Cellarity | February 11, 2022

news image

Cellarity, a life sciences company founded by Flagship Pioneering to encode and simulate human biology to reimagine the way we create medicines, announced today the expansion of its executive leadership team with three key appointments. As Chief Scientific Officer, Laurens Kruidenier, Ph.D., will lead the continued evolution of Cellarity’s platform and pipeline and oversee cross functional integration across all aspects of computation, drug creation, and optimization. As Chief People Offic...

Read More
news image

AGC BIOLOGICS TO PARTICIPATE IN FIRST-EVER BIO DIGITAL CONFERENCE

AGC Biologics | May 14, 2020

AGC Biologics, a global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), will be participating in the first-ever BIO Digital event. BIO International Conference is holding its annual event virtually this year in order to safely connect industry experts amidst the COVID-19 global pandemic. The event, which takes place June 8 - 12, brings together capital, scientific and development expertise that is required to turn promising innovation into successful medicine....

Read More
news image

CELL AND GENE THERAPY

BIOINVENT AND TRANSGENE RECEIVE CTA APPROVAL FOR PHASE L/LLA STUDY OF NOVEL ONCOLYTIC VACCINIA VIRUS BT-001

BioInvent | December 22, 2020

BioInvent International AB ("BioInvent") (OMXS: BINV), a biotech organization focused in on the discovery and development of novel and first-in-class immune-modulatory antibodies for cancer immunotherapy, and Transgene (Euronext Paris: TNG), a biotech organization that designs and develops infection based for the therapy of cancer, reported they have received administrative endorsement in Belgium for a clinical trial application (CTA) for a Phase l/lla study of the novel oncolytic vacc...

Read More
news image

MEDTECH

BIOTECH START-UP AANIKA BIOSCIENCES LANDS INITIAL $12M FUNDING FOR CUTTING-EDGE FOOD TRACING TECHNOLOGY

Aanika Biosciences | December 01, 2021

Biotech start-up Aanika Biosciences today announced the initial closing of its $12 million Series A round, led by Jon Cholak of Adit Ventures along with existing investors Draper Associates and SOSV. The investment will help scale the company’s food tracing technology platform, advance research and expand its Brooklyn food safety and manufacturing facility to approximately 30,000 square feet. Aanika's proprietary technology is designed to accelerate the speed and accurac...

Read More
news image

INDUSTRIAL IMPACT

CELLARITY EXPANDS LEADERSHIP TEAM TO CONTINUE EVOLUTION OF A BREAKTHROUGH PLATFORM TO ENCODE BIOLOGY AND PURPOSEFULLY CREATE NEW MEDICINES

Cellarity | February 11, 2022

Cellarity, a life sciences company founded by Flagship Pioneering to encode and simulate human biology to reimagine the way we create medicines, announced today the expansion of its executive leadership team with three key appointments. As Chief Scientific Officer, Laurens Kruidenier, Ph.D., will lead the continued evolution of Cellarity’s platform and pipeline and oversee cross functional integration across all aspects of computation, drug creation, and optimization. As Chief People Offic...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us